ENDRA Life Sciences Inc.

Nasdaq:NDRA

Electromedical & Electrotherapeutic Apparatus·ANN ARBOR, MI

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/14/25	→
10-Q	Q2 2025	6/30/25	8/14/25	→
10-Q	Q1 2025	3/31/25	5/15/25	→
10-K/A	FY 2024	12/31/24	4/7/25	→
10-K	FY 2024	12/31/24	3/31/25	→
10-Q/A	Q3 2024	9/30/24	11/21/24	→
↓

Earnings Releases (8-K)

25 shown

Filed	Period
7/9/25	Q2 FY2025	→
5/15/25	Q2 FY2025	→
3/31/25	Q1 FY2025	→
11/15/24	Q4 FY2024	→
8/23/24	Q3 FY2024	→
5/14/24	Q2 FY2024	→
↓

News (8-K)

55 shown

Filed	Type	Description
12/15/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
11/28/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
11/14/25	Other	Other Events	→
10/30/25	Agreement	Entry into a Material Definitive Agreement	→
10/23/25	Reg FD	Regulation FD Disclosure	→
10/15/25	Agreement	Entry into a Material Definitive Agreement	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
11/26/25	424B4	424B4	→
11/6/25	S-3	REGISTRATION STATEMENT	→
10/30/25	424B5	PROSPECTUS SUPPLEMENT	→
10/28/25	ARS	ARS	→
7/25/25	S-1/A	FORM S-1/A	→
7/16/25	S-1/A	FORM S-1/A	→
↓

Filing History(506 filings)

TypeDateAccessionPeriodSize

Mar 4, 2026

0001193125-26-0922534

Mar 2, 2026

4.8 KB

Mar 4, 2026

0001193125-26-0922514

Mar 2, 2026

4.8 KB

Jan 23, 2026

0001193125-26-0214154

Jan 21, 2026

4.8 KB

Jan 23, 2026

0001193125-26-0214144

Jan 21, 2026

4.7 KB

Jan 23, 2026

0001193125-26-0214134

Jan 21, 2026

4.6 KB

Jan 23, 2026

0001193125-26-0214124

Jan 21, 2026

4.7 KB

Jan 23, 2026

0001193125-26-0214114

Jan 21, 2026

4.7 KB

8-K

Dec 15, 2025

0001213900-25-121374CURRENT REPORT

Dec 9, 2025

214.1 KB

8-K

Nov 28, 2025

0001213900-25-116103CURRENT REPORT

Nov 28, 2025

308.7 KB

SCHEDULE 13D

Nov 26, 2025

0000898432-25-000936

—

10.2 KB

424B4

Nov 26, 2025

0001213900-25-115097PROSPECTUS

—

230.7 KB

SCHEDULE 13G/A

Nov 14, 2025

0001079973-25-001775

—

7.9 KB

8-K

Nov 14, 2025

0001213900-25-110897CURRENT REPORT

Nov 14, 2025

191.3 KB

10-Q

Nov 14, 2025

0001213900-25-110887QUARTERLY REPORT

Sep 30, 2025

3.9 MB

SCHEDULE 13G/A

Nov 14, 2025

0001079973-25-001729

—

7.7 KB

S-3

Nov 6, 2025

0001213900-25-107232REGISTRATION STATEMENT

—

451.8 KB

SCHEDULE 13G

Oct 30, 2025

0001213900-25-103810

—

10.0 KB

8-K

Oct 30, 2025

0001213900-25-103707CURRENT REPORT

Oct 29, 2025

536.0 KB

424B5

Oct 30, 2025

0001213900-25-103705PROSPECTUS SUPPLEMENT

—

517.6 KB

SCHEDULE 13G

Oct 28, 2025

0001947975-25-000019

—

20.4 KB

ARS

Oct 28, 2025

0001654954-25-012257ARS

Dec 31, 2024

28.5 MB

DEFA14A

Oct 28, 2025

0001654954-25-012256DEFA 14A

—

402.7 KB

DEF 14A

Oct 28, 2025

0001654954-25-012254DEF 14A

Dec 31, 2024

1.8 MB

Oct 24, 2025

0001681682-25-000004

—

11.3 KB

8-K

Oct 23, 2025

0001654954-25-012084FORM 8-K

Oct 23, 2025

251.1 KB

25 filings shown

ENDRA Life Sciences Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(506 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
10/28/25	DEFA14A	DEFA 14A	→
10/28/25	DEF 14A	DEF 14A	→
10/17/25	PRE 14A	PRE 14A	→
9/17/24	DEFA14A	DEFA 14A	→
9/16/24	DEF 14A	DEF 14A	→
9/6/24	PRE 14A	FORM PRE 14A	→
↓

Filed	Form	Description
3/4/26	4	4	→
3/4/26	4	4	→
1/23/26	4	4	→
1/23/26	4	4	→
1/23/26	4	4	→
1/23/26	4	4	→
↓